6515--Treatment Modality for Management of Ocular Surface and Eyelid Disease

This Sources Sought Notice (Solicitation Number: 36C24426Q0811) is issued by the Department of Veterans Affairs, Network Contracting Office 4, on behalf of the Coatesville VA Medical Center Optometry Department in Pennsylvania. The VA is conducting market research to identify potential qualified sources capable of providing a new, FDA-approved system for the management of ocular surface and eyelid diseases. The required technology must treat conditions such as dry eye syndrome, meibomian gland disease, blepharitis, Acne Rosacea, and surrounding skin conditions. Eligible systems must utilize dual-frequency monopolar Radio Frequency (RF) and electronic dynamic muscle stimulation (DMS) to safely deliver heat and restore muscle tone across all patient skin tones without causing depigmentation. Key salient characteristics include a non-pigment-dependent system, multiple RF frequencies, a touch-screen display, rounded eye-contoured electrodes, automatic treatment presets, and zero post-procedure downtime. The Lumenis BE OptiLift System is cited as a brand-name reference for salient characteristics. In addition to supplying the device, the contractor must handle delivery, assembly, inspection, carton recycling, and on-site staff training during normal business hours. Responses from interested vendors—detailing company information, business size status, and product capabilities—must be submitted via email to Contract Specialist Jeff Mann by July 27, 2026, at 6:00 AM Eastern Time. This notice is strictly for market research and does not constitute a formal solicitation.